Federal Register / Vol. 71, No.
123 / Tuesday, June 27, 2006 / Notices 36531
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 28014 (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer’s
Disease Clinical Trials.
Date: July 12, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Alzheimer’s
Disease Clinical Trials.
Date: July 12, 2006.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Ramesh Vemuri, PhD,
Scientific Review Office, National Institute
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C–212, Bethesda,
MD 20892, 301–402–7700, rv23r@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel, Health and
Aging.
Date: July 25, 2006.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 28014 (Telephone Conference
Call).
Contact Person: William Cruce, PhD,
Health Scientist Administrator, Scientific
Review Office, National Institute on Aging,
National Institutes of Health, Room 2C–212,
7201 Wisconsin Avenue, Bethesda, MD
20814, 301–402–7704, crucew@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: June 19, 2006.
sroberts on PROD1PC70 with NOTICES
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5685 Filed 6–26–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005 19:44 Jun 26, 2006 Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, NEUROAIDS SNRP UPR.
Date: June 22–23, 2006.
Time: 7:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel El Confento, 100 Cristo Street,
Old San Juan, Puerto Rico 00901.
Contact Person: Phillip F. Wiethorn,
Scientific Review Administrator, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard,
MSC 9529, Neuroscience Center, Room 3203,
Bethesda, MD 20892–9529, (301) 496–5388,
wiethorp@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: June 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5686 Filed 6–26–06; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
imaging and bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, ZEB1 OSR C 01
2006 Quantum Grants.
Date: July 17–18, 2006.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Clarion Hotel Bethesda Park, 8400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Prabha L. Atreya, PhD.,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
Biomedical Imaging, and Bioengineering,
Bethesda, MD 20892, (301) 496–8633,
atreyapr@mail.nih.gov.
Dated: June 14, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5688 Filed 6–26–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases, Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Lymphocyte Survival and
Death.
27JNN1
 36532 Federal Register / Vol. 71, No. 123 / Tuesday, June 27, 2006 / Notices
Date: July 21, 2006.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3121, Bethesda, MD 20817 (Telephone
Conference Call).
Contact Person: Paul A. Amstad, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, DHHS/National Institutes of
Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, 301–402–
7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 15, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5691 Filed 6–26–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Burn Injury and Alcohol Exposure:
Neuroimmunoendocrine Interations.
Date: July 12, 2006.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of General
Medical Sciences, Office of Scientific
Review, 45 Center Drive, 3AN18, Bethesda,
sroberts on PROD1PC70 with NOTICES
MD 20892 (Telephone Conference Call).
Contact Person: Brian R. Pike PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
VerDate Aug<31>2005 19:44 Jun 26, 2006 Jkt 208001
Bethesda, MD 20892, 301–594–3907,
pikbr@mail.nih.gov.
Name of Committee: Minority Programs
Review Committee, MBRS Review
Subcommittee B.
Date: July 13, 2006.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Clarion Hotel Bethesda Park, 8400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Rebecca H. Johnson, PhD,
Office of Scientific Review, National Institute
of General Medical Sciences, National
Institutes of Health, Natcher Building, Room
3AN18C, Bethesda, MD 20892, 301–594–
2771, johnsonrh@nigms.nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and Development
Biology Research; 93.88, Minority Access to
Research Careers; 93.96, Special Minority
Initiatives, National Institutes of Health,
HHS)
Dated: June 16, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5692 Filed 6–26–06; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, HCV and Immune
Response.
Date: July 11, 2006.
Time: 6:30 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 E:\FR\FM\27JNN1.SGM
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
PhD, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 748, 6707
Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594–7791,
goterrobinsonc@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Limited
Competition for Urinary Incontinence Trials
Network.
Date: July 24, 2006.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Carol J. Goter-Robinson,
Phd, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 748, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7791,
goterrobinsonc@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Short Term
Training.
Date: July 26, 2006.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Dan E. Matsumoto, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 749, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8894, matsumotod@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Molecular
Mechanisms of Cholesterol Absorption.
Date: July 27, 2006.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Dan Matsumoto, PhD.,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 749, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8894, matsumotod@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Study, Prevention,
and Treatment of Kidney Diseases.
Date: July 27, 2006.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
27JNN1